action of glp-1 agonist

action of glp-1 agonist GLP1-GIP receptor co-agonists: a promising evolution in the treatment type 2 diabetes | Acta Diabetologica GLP-1 and Anesthesia: Considerations and

Name: action of glp-1 agonist GLP1-GIP receptor co-agonists: a promising evolution in the treatment type 2 diabetes | Acta Diabetologica GLP-1 and Anesthesia: Considerations and
Brand: actil.am
SKU: 78959857525
Price: 29.16 USD
Availability: InStock
Rating: 4.423 (20 reviews)

SKU: 78959857525

4.4

USD29.16 USD50.16

Pay in 4 interest-free payments of $7.29 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 31 - Sep 5

Description

The DPP-4 inhibitor CV safety outcome trials have unequivocally demonstrated that DPP-4 inhibition is not associated with any increased risk of major adverse CV events (MACE), with the four trials so far published (124127) having hazard ratios (HR) for the primary outcome of between 0.96 and 1.02 (Table 2)